Circulating Adhesion Molecules in Gastric Cancer
Author Information
Author(s): M Benekli, IH Gullu, G Tekuzman, MC Sava, M Hayran, G Has9eIik, D Firat
Primary Institution: Institute of Oncology, Hacettepe University School of Medicine, Ankara, Turkey
Hypothesis
The study investigates the relationship between serum levels of soluble intercellular adhesion molecule-1 (sICAM-1) and soluble E-selectin (sE-selectin) in patients with gastric cancer and their association with metastasis and prognosis.
Conclusion
Increased serum levels of sICAM-1 are associated with widespread disease in gastric cancer, while elevated sE-selectin levels correlate with poorer prognosis.
Supporting Evidence
- Serum sICAM-1 levels were significantly increased in patients with gastric cancer.
- sE-selectin levels did not differ significantly from controls.
- Elevated sICAM-1 levels correlated with distant metastasis.
- Higher sE-selectin levels were associated with poorer prognosis.
- Serum levels of sICAM-1 and sE-selectin correlated with CEA levels.
Takeaway
This study found that patients with stomach cancer have higher levels of a specific protein in their blood, which might help doctors understand how advanced the cancer is.
Methodology
Serum levels of sICAM-1 and sE-selectin were measured using enzyme-linked immunosorbent assay (ELISA) in patients with gastric cancer and compared to healthy controls.
Limitations
The study had a small sample size and a short follow-up period for survival analysis.
Participant Demographics
The study included 27 patients (18 males and 9 females) with a median age of 60 years, diagnosed with gastric adenocarcinoma.
Statistical Information
P-Value
P < 0.0001 for sICAM-1 levels in gastric cancer patients compared to controls.
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website